Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
  2. Davar, Diwakar; Morrison, Robert M; Dzutsev, Amiran K; Karunamurthy, Arivarasan; Chauvin, Joe-Marc; Amatore, Florent; Deutsch, Julie S; Das Neves, Rodrigo X; Rodrigues,Richard; McCulloch, John A; Wang, Hong; Hartman, Douglas J; Badger, Jonathan H; Fernandes, Miriam R; Bai, Yulong; Sun, Jie; Cole, Alicia M; Aggarwal, Poonam; Fang, Jennifer R; Deitrick, Christopher; Bao, Riyue; Duvvuri, Umamaheswar; Sridharan, Shaum S; Kim, Seungwon W; A Choudry, Haroon; Holtzman, Matthew P; Pingpank, James F; O'Toole, James Patrick; DeBlasio, Richelle; Jin, Yang; Ding, Quanquan; Gao, Wentao; Groetsch, Christopher; Pagliano, Ornella; Rose, Amy; Urban, Corey; Singh, Jagjit; Divarkar, Prajan; Mauro, David; Bobilev, Dmitri; Wooldridge, James; Krieg, Arthur M; Fury, Matthew G; Whiteaker, Jeffrey R; Zhao, Lei; Paulovich, Amanda G; Najjar, Yana G; Luke, Jason J; Kirkwood, John M; Taube, Janis M; Park, Hyun Jung; Trinchieri, Giorgio; Zarour, Hassane M
  3. Cancer Cell. 2024, Oct 30;
  1. 2.   Innate Immune Stimulation Using 3D Wireframe DNA Origami
  2. Du, Rebecca R; Cedrone,Edward; Romanov, Anna; Falkovich, Reuven; Dobrovolskaia,Marina; Bathe, Mark
  3. ACS Nano. 2022, Dec 02;
  1. 3.   Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
  2. Shirota, Y.; Shirota, H.; Klinman, D. M.
  3. Journal of Immunology. 2012, Feb; 188(4): 1592-1599.
  1. 4.   The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides
  2. Yamamoto, M.; Sato, T.; Beren, J.; Verthelyi, D.; Klinman, D. M.
  3. Biomaterials. 2011, Jun; 32(18): 4238-4242.
  1. 5.   CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity
  2. Shirota, H.; Klinman, D. M.
  3. Cancer Immunology Immunotherapy. 2011, May; 60(5): 659-669.
  1. 6.   CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2
  2. Iribarren, P.; Chen, K. Q.; Hu, J. Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Uranchimeg, B.; Wang, J. M.
  3. Faseb Journal. 2005, OCT; 19(12): Published as FJ Express article on October 11, 2005.
  1. 7.   CpG Oligodeoxynucleotides as Adjuvants for Clinical Use
  2. Shirota, H.; Klinman, Dennis
  3. 2017; (Immunopotentiators in Modern Vaccines, 2nd Edition): 163-198.
  1. 8.   CpG Oligonucleotides as Vaccine Adjuvants
  2. Kayraklioglu, Neslihan; Horuluoglu, Begum; Klinman,Dennis
  3. DNA VACCINES. 2021 2197: 51-85.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel